Indication

Major depressive disorder

Major depressive disorder is a common, disabling psychiatric mood disorder primarily affecting the central nervous system across pediatric, adult, and geriatric populations. Read more about Major depressive disorder

666 drugs 179 manufacturers

Advertisement

Drugs that treat it

Common Major depressive disorder therapies.

Showing 154–162 of 666 drugs

DULOXETINE HCL

ANTIDEPRESSANTS·MAJOR DEPRESSIVE DISORDER·+5
TORRENT PHARMAC

DULOXETINE HCL

ANTIDEPRESSANTS·MAJOR DEPRESSIVE DISORDER·+5
SUN PHARMA GLOB

DULOXETINE HCL

ANTIDEPRESSANTS·MAJOR DEPRESSIVE DISORDER·+5
LUPIN PHARMACEU

FLUOXETINE HCL

ANTIDEPRESSANTS·MAJOR DEPRESSIVE DISORDER·+5
Mylan Pharmaceuticals
Filter & compare in the drug finder →Opens the drug finder with Major depressive disorder preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Major depressive disorder.

Major depressive disorder is a common, disabling psychiatric mood disorder primarily affecting the central nervous system across pediatric, adult, and geriatric populations.

It is clinically defined by persistent depressed mood or profound anhedonia lasting at least two consecutive weeks, accompanied by significant distress or impairment in social, occupational, and physical functioning.

Diagnostic features include alterations in sleep and appetite, psychomotor agitation or retardation, fatigue, impaired concentration, inappropriate feelings of worthlessness or guilt, and recurrent suicidal ideation.

Pathophysiologically, the condition involves complex multifactorial disruptions across monoaminergic neurotransmission, neuroplasticity, inflammatory signaling, and hypothalamic-pituitary-adrenal axis regulation.

Personalize your experience

Follow Major depressive disorder and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it